You Position: Home > Paper
Short hairpin RNA-mediated downregulation of the Pokemon gene Suppresses proliferation and promotes apoptosis in HepG2 cells
( views:286, downloads:0 )
- Author:
- No author available
- Journal Title:
- WORLD CHINESE JOURNAL OF DIGESTOLOGY
- Issue:
- 30
- DOI:
- 10.3969/j.issn.1009-3079.2009.30.010
- Key Word:
- Pokemon;短发夹状RNA;细胞增殖;细胞凋亡;H-ras
Abstract： 目的:观察携带shRNA的重组质粒对肝癌细胞HepG2增殖及凋亡的影响,并初步探讨其分子机制.方法:设计3对针对Pokcmon基因不同位点的shRNA片段的真核表达载体,脂质体介导转染肝癌细胞株HepG2细胞.RT-PCR及Western blot检测转染前后Pokemon mRNA及蛋白质的 表达,MTT和流式细胞仪分析转染后细胞增殖及凋亡的变化,RT-PCR检测其可能的下游因子β-catenin及H-ras的表达.结果:成功构建含shRNA片段的重组质粒,依次命名为pshRNA1、2、3.转染HepG2细胞后,Pokemon基因的mRNA及蛋白质表达水平明显下调,以pshRNA2最强,抑制率分别为75.2%(RNA水平)和72.6l%(蛋白质水平).MTT显示pshRNA2可明显抑制细胞增殖;流式细胞仪测定转染后细胞凋亡增加;RT-PCR显示下游因子H-ras的表达明显降低(P＜0.05),而β-catenin的表达没有变化(P＞0.05).结论:采用RNAi技术可以特异性阻断Pokemon 基因的表达;Pokemon基因有促进肝癌细胞株增殖及抑制其凋亡的作用,该效应可能与下调其下游因子H-ras的表达有关.
- [1]Isabel Fabregat.Dysregulation of apoptosis in hepatocellular carcinoma cells[J].2009,(5).
- [2]Kai-Feng Pan,Wan-Guo Liu,Lian Zhang,etc.Mutations in components of the Wnt signaling pathway in gastric cancer[J].2008,(10).
- [3]吴阳,张水军,丁月超.Pokemon基因在原发性肝癌组织中的表达及意义[J].2008,(5).
- [4]Worrawit Wanitsuwan,Samommas Kanngum,Teeranut Boonpipattanapong,etc.Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers[J].2008,(39).
- [5]Francesco Feo,Maddalena Frau,Rosa Maria Pascale.Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis[J].2008,(43).
- [6]Agrawal DK,Agrawal A,Murphy RF,etc.Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.[J].2006,81(2).
- [7]Romano PR,Pachuk CJ,McCallus DE.RNA interference-mediated prevention and therapy for hepatocellular carcinoma.[J].2006,25(27).
- [8]Apostolopoulou K,Pateras IS,Evangelou K,etc.Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.[J].2007,213(3).